Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
STRO
STRO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
STRO News
Sutro Biopharma Prices 7.87M Share Offering at $13.98 Each
6d ago
seekingalpha
Sutro Biopharma CEO to Present at 44th J.P. Morgan Healthcare Conference
Jan 07 2026
Globenewswire
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing
Dec 19 2025
PRnewswire
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing
Dec 19 2025
Newsfilter
Sutro Biopharma Regains Nasdaq Compliance with $1 Share Price Post Reverse Split
Dec 17 2025
Globenewswire
Sutro Biopharma Regains Nasdaq Compliance with $1 Share Price Post Reverse Split
Dec 17 2025
Newsfilter
Sutro Biopharma Grants 24,500 Stock Options to Attract New Employees
Dec 16 2025
Globenewswire
Sutro Biopharma Grants 24,500 Stock Options to Attract New Employees
Dec 16 2025
Newsfilter
Sutro Biopharma Initiates Phase 1 Trial of STRO-004, Initial Data Expected Mid-2026
Dec 03 2025
Globenewswire
Sutro Biopharma Approves 1-for-10 Reverse Stock Split to Meet Nasdaq Compliance
Dec 01 2025
Globenewswire
Sutro Biopharma Implements 1-for-10 Reverse Stock Split
Dec 01 2025
NASDAQ.COM
Sutro Biopharma Showcases Advanced ADC Innovations During Virtual R&D Day
Nov 12 2025
Newsfilter
FDA Strengthens Survival Criteria as Cancer Drug Market Reaches $866B Milestone
Aug 28 2025
Newsfilter
RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains?
Jun 24 2025
NASDAQ.COM
Strength Seen in Mobileye (MBLY): Can Its 11.6% Jump Turn into More Strength?
Jun 24 2025
NASDAQ.COM
Piper Sandler Upgrades Sutro Biopharma to Overweight, Maintains Price Target to $2
Jun 16 2025
Benzinga
Show More News
